Development and validation of machine learning prognostic models for overall survival in non-surgical prostate cancer patients with bone metastases.
2/5 보강
OpenAlex 토픽 ·
Prostate Cancer Diagnosis and Treatment
Prostate Cancer Treatment and Research
Artificial Intelligence in Healthcare and Education
[OBJECTIVE] To construct and interpret a machine learning model for predicting overall survival in nonsurgical prostate cancer with bone metastases (PCBM).
APA
Qilin Yang, Ben Wang, et al. (2026). Development and validation of machine learning prognostic models for overall survival in non-surgical prostate cancer patients with bone metastases.. The aging male : the official journal of the International Society for the Study of the Aging Male, 29(1), 2644725. https://doi.org/10.1080/13685538.2026.2644725
MLA
Qilin Yang, et al.. "Development and validation of machine learning prognostic models for overall survival in non-surgical prostate cancer patients with bone metastases.." The aging male : the official journal of the International Society for the Study of the Aging Male, vol. 29, no. 1, 2026, pp. 2644725.
PMID
41839858 ↗
Abstract 한글 요약
[OBJECTIVE] To construct and interpret a machine learning model for predicting overall survival in nonsurgical prostate cancer with bone metastases (PCBM).
[METHODS] Data from 3,378 SEER database patients were utilized to develop machine learning survival models, with the best-performing model visually interpreted using SHAP.
[RESULTS] The Extra Survival Trees (EST) model performed best (validation AUC = 0.694, C-index = 0.643). SHAP analysis identified the Gleason score as the most critical survival factor, significantly outweighing clinical T stage. Visceral metastasis and advanced age also markedly increased mortality risk.
[CONCLUSION] The EST model effectively assesses OS in nonsurgical PCBM. The Gleason score holds greater prognostic value than local anatomical staging in this cohort, suggesting clinicians should prioritize early, aggressive combination treatments for high-Gleason, high-burden patients.
[METHODS] Data from 3,378 SEER database patients were utilized to develop machine learning survival models, with the best-performing model visually interpreted using SHAP.
[RESULTS] The Extra Survival Trees (EST) model performed best (validation AUC = 0.694, C-index = 0.643). SHAP analysis identified the Gleason score as the most critical survival factor, significantly outweighing clinical T stage. Visceral metastasis and advanced age also markedly increased mortality risk.
[CONCLUSION] The EST model effectively assesses OS in nonsurgical PCBM. The Gleason score holds greater prognostic value than local anatomical staging in this cohort, suggesting clinicians should prioritize early, aggressive combination treatments for high-Gleason, high-burden patients.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- The role and prospects of the Fudan classification in precision medicine for triple-negative breast cancer.
- Metabolic reprogramming of efferocytosis in the tumour microenvironment: From apoptotic-cell clearance to therapeutic targeting.
- NFYA transcriptionally activates GPX4 inhibiting ferroptosis in colorectal cancer.
- Tumor location stratifies lymph node metastasis risk and prognosis in gastric cancer: A retrospective analysis of multicenter data and SEER database.
- A novel prognostic model for colon adenocarcinoma based on cofactor and vitamin metabolism-related genes.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.